# Baxter Pharmaceutical Solutions, LLC - Inspection Records Source: https://www.keypedia.com/companies/baxter-pharmaceutical-solutions-llc/dd8344ef-ad46-49b8-8b39-fb1d8cb518d8 > Inspection records and compliance data for Baxter Pharmaceutical Solutions, LLC in Bloomington, Indiana. Access full analysis and detailed observations. --- ## Details - Name: Baxter Pharmaceutical Solutions, LLC - FEI Number: 1000115571 - City: Bloomington - State: Indiana - Country Name: United States - Address Line 1: 927 S Curry Pike - Zip Code: 47403 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - Baxter Pharmaceutical Solutions, LLC - Unknown Date](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/18f3a643-f7a3-4880-971e-adfe35384dca) — source: FDA, date: Invalid Date - [483 - Baxter Pharmaceutical Solutions, LLC - Unknown Date](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/c2258424-7ec3-4182-846d-ce66b310826f) — source: FDA, date: Invalid Date - [FDA Inspection 1290838 - Baxter Pharmaceutical Solutions, LLC - 2025-12-11](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/f0d97ad5-94cd-4b98-9161-ab08db98b7a2) — source: FDA, date: December 11, 2025 - [FDA Inspection 1290838 - Baxter Pharmaceutical Solutions, LLC - 2025-12-11](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/e3888c4a-f3ae-412d-ba8b-7ba36c4e3491) — source: FDA, date: December 11, 2025 - [FDA Inspection 1242468 - Baxter Pharmaceutical Solutions, LLC - 2024-09-24](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/5e099ee8-4e07-4b90-85f5-484e0918b190) — source: FDA, date: September 24, 2024 - [FDA Inspection 1242468 - Baxter Pharmaceutical Solutions, LLC - 2024-09-24](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/5c2adc75-a229-4745-ab02-1a0b1101e671) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2024 - [FDA Inspection 1243512 - Baxter Pharmaceutical Solutions, LLC - 2024-07-26](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/b3d0c5d3-833d-424f-9987-928d1ad62f9f) — source: FDA, date: July 26, 2024 - [483 - Baxter Pharmaceutical Solutions, LLC - 2024-02-20](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/eb37852c-d304-4aa1-b686-b66af3adb296) — source: FDA, date: February 20, 2024 - [FDA Inspection 1230675 - Baxter Pharmaceutical Solutions, LLC - 2024-02-20](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/1096b217-7488-424a-96e2-821302093f1b) — source: FDA, date: February 20, 2024 - [FDA Inspection 1200813 - Baxter Pharmaceutical Solutions, LLC - 2023-02-17](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/eaea16ee-69c0-4bb3-9fca-7cbd0d0b5ca7) — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2023 - [483 - Baxter Pharmaceutical Solutions, LLC - 2021-11-10](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/c91e52f6-4e43-430a-b928-8ebf52c805f1) — source: FDA, date: November 10, 2021 - [483 - Baxter Pharmaceutical Solutions, LLC - 2021-11-10](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/e58a0478-5a31-4b0c-bf8f-43a2a2cd7673) — source: FDA, date: November 10, 2021 - [FDA Inspection 1157719 - Baxter Pharmaceutical Solutions, LLC - 2021-11-10](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/3bdda7e3-c5df-401e-ac25-7e71d3a8fa2f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2021 - [FDA Inspection 1060004 - Baxter Pharmaceutical Solutions, LLC - 2018-05-23](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/78b00663-3646-4ecc-ae32-32d99f9f356f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2018 - [FDA Inspection 1060004 - Baxter Pharmaceutical Solutions, LLC - 2018-05-23](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/a8a9268a-9813-4e4f-b671-eae53fa1f68d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2018 ## Related Companies - [Vet Pharma Friesoythe GmbH](https://www.keypedia.com/companies/vet-pharma-friesoythe-gmbh/d5ae589a-9f1d-41b9-8cc8-1b3113f07a7d) - [Corixa Corporation](https://www.keypedia.com/companies/corixa-corporation/540054c0-cf35-42d2-9056-a9ae897ff412) - [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/1a3cc4bb-fac0-4252-89c5-c4ed77ea95f3) - [InfoRLife SA](https://www.keypedia.com/companies/inforlife-sa/41fbd76a-a030-4e8b-ace1-cc13b1dc52b1) - [Fareva Unterach GmbH](https://www.keypedia.com/companies/fareva-unterach-gmbh/04c4438b-dd74-4814-8d9d-74a9aaba9026) - [Intervet International GmbH](https://www.keypedia.com/companies/intervet-international-gmbh/ae83e558-c533-4439-b820-58981fa727a2) - [Steriscience Specialties Private Limited](https://www.keypedia.com/companies/steriscience-specialties-private-limited/f2814c8b-daff-42a4-abe2-59947a5bda3d) - [Fresenius Medical Care de Mexico](https://www.keypedia.com/companies/fresenius-medical-care-de-mexico/a425662c-8722-4035-b4f4-5cf408ae88ac) - [NextPharma OY](https://www.keypedia.com/companies/nextpharma-oy/5b55d776-23ac-485d-bcb8-0a0c74091608) - [Solventum US LLC](https://www.keypedia.com/companies/solventum-us-llc/8195e7c6-5daf-4fbd-817a-9380b229bbcc) ## Related Officers - [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb) - [National Expert, Pharmaceutical](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108) - [Brenton Collins, CSO](https://www.keypedia.com/people/brenton-collins-cso/0dcb7303-2d8b-469c-a595-80b6c2a76099) - [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da) - [Investigator](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc) - [Scott Ballard, CSO, National Expert](https://www.keypedia.com/people/scott-ballard-cso-national-expert/eddbe750-64dc-49e7-8b2b-5125ab381424)